Retraction notices

Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis

Type
Retraction
Notice date
11/4/2024 0:00
Journal
Experimental and Therapeutic Medicine
Publisher
Spandidos
Notice DOI
10.3892/etm.2024.12760
Original paper DOI
10.3892/etm.2017.5404

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.